Pharmacogenomics holds great application for individuals with mental disorders, which according to the NIMH, is 1 in 4 adults in the United States. Because prescribing treatment can be hit or miss, the fact that it takes up to 6 weeks to see if a drug works, and noting that 40% of patients don't respond to the 1st drug prescribed, testing patients before treatment to determine if they have a genetic variation that might predict how the patient would respond to antidepressants is not only a great thing, it's a value-ad requirement for patient-centered care and precision medicine. Pharmacogenomics is an exciting new way to match medications with patients and potentially save dollars and lives.
THERE'S A Precision MEDICINE PHARMACIST in THE HOUSE
Accelerating a new era of medicine that transforms the way health is measured, delivered and accessed.